Home » Topics » Regulatory

Regulatory
RSS

Nycomed Amersham receives approvable letter for extended use of Myoview

Feb. 29, 2000

Angiotech announces promising results from phase I/II SPMS study

Feb. 29, 2000

Extended-release metformin shows good phase I results

Feb. 28, 2000

Allergan and Dura enter commercialization agreement for multiple products

Feb. 25, 2000

Use of FK-506 as topical analgesic disclosed

Feb. 25, 2000

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Feb. 25, 2000

New Videx capsule formulation approved in France

Feb. 25, 2000

Remicade recommended for approval in E.U. for treatment of rheumatoid arthritis

Feb. 24, 2000

Nastech's NDA for intranasal scopolamine not accepted for filing

Feb. 24, 2000

Pregabalin now claimed for renal colic-associated pain

Feb. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...